NCT01632579View on ClinicalTrials.gov

A Single Dose Study of LY3023703 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY3023703

Administered orally

DRUG

Placebo

Administered orally

DRUG

Celecoxib

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01632579 - A Single Dose Study of LY3023703 in Healthy Participants | Biotech Hunter | Biotech Hunter